America’s opioid drug epidemic has struck hard in Michigan. But now, a team from the University of Michigan is striking back at a key factor: opioid prescriptions for patients before and after surgery.
On October 13, 2016 a Centers for Disease Control (CDC) Health Advisory and Food & Drug Administration (FDA) Safety Communication announced that the Stöckert 3T heater/cooler devices by LivaNova PLC (formerly the Sorin Group) may have been contaminated with Mycobacterium chimaera (M.Chimaera), a rare type nontuberculous mycobacterium (NTM), during manufacturing.
Researchers at the University of Michigan Life Sciences Institute and U-M Health System Department of Surgery see promise in a new approach to increasing long-term survival after organ transplant — one that’s showing encouraging results in animal models.
A new test can guide treatment for patients with graft versus host disease (GVHD), an often life-threatening complication of bone marrow and stem cell transplants, according to research from the University of Michigan published in Lancet Haematology this month.
The University of Michigan in partnership with the American Society of Transplant Surgeons (ASTS) and Arbor Research Collaborative for Health, are pleased to announce they have been selected to continue operating the National Living Donor Assistance Center (NLDAC).
A new class of drugs reduced the risk of patients contracting a serious and often deadly side effect of lifesaving bone marrow transplant treatments, according to a study from researchers at the University of Michigan Comprehensive Cancer Center.
The University of Michigan already has three wins over Ohio State this season, but the real winners are those who need the life-saving donations secured during annual challenges between the Wolverines and the Buckeyes.
Researchers from the University of Michigan Comprehensive Cancer Center have identified new proteins that control the function of critical immune cell subsets called T-cells, which are responsible for a serious and often deadly side effect of lifesaving bone marrow transplants.
Ann Arbor, Mich. – People given the gift of life – blood, organs, tissue or bone marrow – are grateful every day for the hero who gave them a second chance at life. In an inspirational new video, U-M patients share how their hero impacted them and their families with a life-saving donation.
The chance of getting infectious encephalitis from an organ transplant is rare, but in an editorial, a U-M expert urges transplant teams, critical care specialists, neurologists, and infectious disease physicians to be aware of the risk.
Spontaneous survivors of acetaminophen overdose have significantly lower overall health compared to survivors or transplant recipients following acute liver failure caused by non-drug induced liver injury
More than 800 people attended the second annual Be a Hero at the Big House donor drive, donating 230 pints of blood, signing up on the Michigan Organ Donor Registry and joining the national bone marrow registry.
After about a 4-year wait, years of dialysis treatments and 65 surgeries, Jai'Wan Davis-Harbour received a successful kidney transplant at C.S. Mott Children's Hospital. Because of a generous organ donor, Jai'Wan, 11, got a second chance at life.
Wolverines for Life, the University of Michigan's initiative to promote life-saving organ and tissue donation, honored a U-M Athletics Department official and a local businessman Thursday for their efforts to promote organ, tissue, blood and bone marrow donations.
The Taubman Health Center on the U-M medical campus draws patients from around the state and the world, for outpatient visits with some of the nation's top specialists. Now, UMHS will renovate, reorganize and revitalize the building, and add to the range of services offered there.